These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor: Mechanistic Insight and Potential Clinical Use. Barreto J; Karathanasis SK; Remaley A; Sposito AC Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):153-166. PubMed ID: 33176449 [TBL] [Abstract][Full Text] [Related]
4. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Chen M; Masaki T; Sawamura T Pharmacol Ther; 2002 Jul; 95(1):89-100. PubMed ID: 12163130 [TBL] [Abstract][Full Text] [Related]
5. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Dunn S; Vohra RS; Murphy JE; Homer-Vanniasinkam S; Walker JH; Ponnambalam S Biochem J; 2008 Jan; 409(2):349-55. PubMed ID: 18092947 [TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase-Oxidized LDL Activates Human Aortic Endothelial Cells through the LOX-1 Scavenger Receptor. El-Hajjar L; Hindieh J; Andraos R; El-Sabban M; Daher J Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269979 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Inoue K; Arai Y; Kurihara H; Kita T; Sawamura T Circ Res; 2005 Jul; 97(2):176-84. PubMed ID: 15961718 [TBL] [Abstract][Full Text] [Related]
8. The discovery of LOX-1, its ligands and clinical significance. Yoshimoto R; Fujita Y; Kakino A; Iwamoto S; Takaya T; Sawamura T Cardiovasc Drugs Ther; 2011 Oct; 25(5):379-91. PubMed ID: 21805404 [TBL] [Abstract][Full Text] [Related]
9. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis]. Morawietz H Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162 [TBL] [Abstract][Full Text] [Related]
10. Native and Oxidized Low-Density Lipoproteins Increase the Expression of the LDL Receptor and the LOX-1 Receptor, Respectively, in Arterial Endothelial Cells. Catar R; Chen L; Zhao H; Wu D; Kamhieh-Milz J; Lücht C; Zickler D; Krug AW; Ziegler CG; Morawietz H; Witowski J Cells; 2022 Jan; 11(2):. PubMed ID: 35053320 [TBL] [Abstract][Full Text] [Related]
11. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells. Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059 [TBL] [Abstract][Full Text] [Related]
12. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis. Stancel N; Chen CC; Ke LY; Chu CS; Lu J; Sawamura T; Chen CH Clin Chem; 2016 Feb; 62(2):320-7. PubMed ID: 26607724 [TBL] [Abstract][Full Text] [Related]
13. Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1. Cimmino G; Cirillo P; Conte S; Pellegrino G; Barra G; Maresca L; Morello A; Calì G; Loffredo F; De Palma R; Arena G; Sawamura T; Ambrosio G; Golino P Cardiovasc Res; 2020 May; 116(6):1125-1135. PubMed ID: 31504248 [TBL] [Abstract][Full Text] [Related]